Company Overview: Monster Digital

Industry News

13 Dec

Monster Digital Receives Requested Extension from Nasdaq Panel

SIMI VALLEY, CA, Dec. 12, 2017 (GLOBE NEWSWIRE) — Monster Digital, Inc. (MSDI) (the “Company” or “Monster Digital”) announced today that on December 11, 2017, it was notified by The NASDAQ Stock Market LLC (“Nasdaq”) that the Nasdaq Hearings Panel (the “Panel”) granted the Company’s request for continued listing...

Read more

5 Dec

Monster Digital Announces Strategic and Legal Developments

SIMI VALLEY, CA, Dec. 04, 2017 (GLOBE NEWSWIRE) — Monster Digital, Inc. (MSDI) (the “Company”) announced today certain strategic and legal developments. The Company announced that it has forwarded Monster, Inc. a notice of termination of that Trademark License Agreement by and between Monster, Inc. and the Company’s wholly-owned...

Read more

30 Nov

Monster Digital, Inc. Provides Update Regarding Anticipated Closing Date for Merger with Innovate Biopharmaceuticals, Inc.

SIMI VALLEY, CA–(Marketwired – Nov 29, 2017) – Monster Digital, Inc. ( NASDAQ : MSDI ) (“Monster Digital” or the “Company”) announced today that the Company and Innovate Biopharmaceuticals, Inc. (“Innovate”) have agreed to work towards the closing (the “Closing”) of the proposed reverse merger (“Merger”) between Monster Digital and Innovate on or...

Read more

10 Nov

Monster Digital, Inc. Announces Successful Stockholder Meeting

SIMI VALLEY, CA–(Marketwired – Nov 10, 2017) – Monster Digital, Inc. ( NASDAQ : MSDI ) (“Monster” or the “Company”) today announced its special meeting of stockholders held on November 9, 2017 went smoothly and all proposals were voted affirmatively and accepted. This included a proposal to adopt the Agreement and Plan of Merger...

Read more

23 Oct

Monster Digital Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing

SIMI VALLEY, CA–(Marketwired – Oct 23, 2017) – Monster Digital Inc., ( NASDAQ : MSDI ), (“Monster Digital” or the “Company”), announced today that, as anticipated, on October 19, 2017, the Company received a letter from the Listing Qualifications Staff (the “Staff”) of The NASDAQ Stock Market LLC (“Nasdaq”) indicating that the Company’s non-compliance...

Read more

3 Jul

Monster Digital and Innovate Biopharmaceuticals Sign Merger Agreement

Effects a public listing of an autoimmune biotechnology company with its first drug expected to enter Phase 3 trials in late 2017 for celiac disease with pivotal data expected by first half 2019 Ulcerative colitis phase 2 clinical trials for INN-108 expected to begin in first half 2018  ...

Read more

2 Jun

Monster Digital Submits Plan With Nasdaq To Regain Compliance

SIMI VALLEY, CA–(Marketwired – Jun 1, 2017) – Monster Digital, Inc. ( NASDAQ : MSDI ) announced today that it has submitted its plan to Nasdaq detailing how it will regain compliance with Nasdaq continued listing requirements. On April 17, 2017, Monster Digital received a letter from Nasdaq indicating that...

Read more

Page 1 of 41234

Enter your email address to receive notifications of new posts by email.

Latest Tweets


Follow this blog

Get every new post delivered right to your inbox.

Email address